Total Payments
$180,817
2024 Payments
$7,609
Companies
8
Transactions
175
Medicare Patients
221
Medicare Billing
$19,952
Payment Breakdown by Category
Consulting$156,071 (86.3%)
Other$13,423 (7.4%)
Travel$8,356 (4.6%)
Food & Beverage$2,967 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $156,071 | 53 | 86.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $9,423 | 15 | 5.2% |
| Travel and Lodging | $8,356 | 47 | 4.6% |
| Honoraria | $4,000 | 1 | 2.2% |
| Food and Beverage | $2,967 | 59 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ViiV Healthcare Company | $81,798 | 37 | $0 (2024) |
| Merck Sharp & Dohme LLC | $55,288 | 61 | $0 (2022) |
| Gilead Sciences, Inc. | $14,954 | 20 | $0 (2022) |
| Janssen Scientific Affairs, LLC | $9,414 | 12 | $0 (2024) |
| Theratechnologies Inc. | $8,619 | 14 | $0 (2019) |
| Janssen Products, LP | $7,525 | 14 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $2,750 | 11 | $0 (2020) |
| EMD Serono, Inc. | $469.00 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $7,609 | 10 | ViiV Healthcare Company ($3,900) |
| 2023 | $31,290 | 14 | ViiV Healthcare Company ($26,716) |
| 2022 | $36,870 | 25 | ViiV Healthcare Company ($17,540) |
| 2021 | $5,380 | 2 | ViiV Healthcare Company ($3,680) |
| 2020 | $12,540 | 7 | ViiV Healthcare Company ($6,440) |
| 2019 | $38,551 | 47 | ViiV Healthcare Company ($19,216) |
| 2018 | $24,512 | 43 | Merck Sharp & Dohme Corporation ($14,001) |
| 2017 | $24,064 | 27 | Merck Sharp & Dohme Corporation ($14,791) |
All Payment Transactions
175 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/09/2024 | ViiV Healthcare Company | — | Consulting Fee | Cash or cash equivalent | $1,300.00 | General |
| 08/05/2024 | ViiV Healthcare Company | — | Consulting Fee | Cash or cash equivalent | $1,300.00 | General |
| 06/18/2024 | Janssen Scientific Affairs, LLC | SYMTUZA (Drug) | Consulting Fee | Cash or cash equivalent | $3,240.00 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 06/17/2024 | ViiV Healthcare Company | — | Consulting Fee | Cash or cash equivalent | $1,300.00 | General |
| 05/31/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $80.00 | General |
| 05/31/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $60.00 | General |
| 05/31/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $18.26 | General |
| 05/31/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $18.26 | General |
| 05/30/2024 | EMD Serono, Inc. | — | Travel and Lodging | Cash or cash equivalent | $217.20 | General |
| 05/30/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $75.28 | General |
| 12/04/2023 | ViiV Healthcare Company | — | Consulting Fee | Cash or cash equivalent | $7,475.00 | General |
| 12/03/2023 | ViiV Healthcare Company | — | Consulting Fee | Cash or cash equivalent | $8,899.53 | General |
| 10/12/2023 | ViiV Healthcare Company | — | Consulting Fee | Cash or cash equivalent | $3,841.92 | General |
| 10/12/2023 | ViiV Healthcare Company | — | Consulting Fee | Cash or cash equivalent | $3,250.00 | General |
| 05/12/2023 | Janssen Scientific Affairs, LLC | SYMTUZA (Drug) | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 05/12/2023 | Janssen Scientific Affairs, LLC | SYMTUZA (Drug) | Travel and Lodging | In-kind items and services | $235.00 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 05/12/2023 | Janssen Scientific Affairs, LLC | SYMTUZA (Drug) | Travel and Lodging | In-kind items and services | $97.75 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 05/12/2023 | Janssen Scientific Affairs, LLC | SYMTUZA (Drug) | Travel and Lodging | In-kind items and services | $97.75 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 05/12/2023 | Janssen Scientific Affairs, LLC | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $52.74 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 05/12/2023 | Janssen Scientific Affairs, LLC | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $36.58 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 05/12/2023 | Janssen Scientific Affairs, LLC | SYMTUZA (Drug) | Travel and Lodging | Cash or cash equivalent | $18.99 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 05/12/2023 | Janssen Scientific Affairs, LLC | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 05/12/2023 | Janssen Scientific Affairs, LLC | SYMTUZA (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Infectious Diseases & Vaccines | ||||||
| 03/28/2023 | ViiV Healthcare Company | — | Consulting Fee | Cash or cash equivalent | $3,250.00 | General |
| 12/20/2022 | Janssen Products, LP | SYMTUZA (Drug) | Consulting Fee | Cash or cash equivalent | $860.00 | General |
| Category: Infectious Diseases & Vaccines | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 53 | 70 | $16,188 | $5,448 |
| 2022 | 1 | 52 | 63 | $15,205 | $5,275 |
| 2021 | 1 | 49 | 59 | $13,101 | $4,737 |
| 2020 | 2 | 67 | 70 | $12,883 | $4,492 |
Total Patients
221
Total Services
262
Medicare Billing
$19,952
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 42 | 56 | $12,200 | $4,077 | 33.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 11 | 14 | $3,988 | $1,371 | 34.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 28 | 33 | $6,930 | $2,643 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 24 | 30 | $8,275 | $2,631 | 31.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 25 | 32 | $7,431 | $2,445 | 32.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 24 | 27 | $5,670 | $2,292 | 40.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 21 | 23 | $3,013 | $1,592 | 52.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 21 | 21 | $4,410 | $1,455 | 33.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 25 | 26 | $5,460 | $1,446 | 26.5% |
About Dr. Todd Brown, M.D
Dr. Todd Brown, M.D is a Internal Medicine healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780642264.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Todd Brown, M.D has received a total of $180,817 in payments from pharmaceutical and medical device companies, with $7,609 received in 2024. These payments were reported across 175 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($156,071).
As a Medicare-enrolled provider, Brown has provided services to 221 Medicare beneficiaries, totaling 262 services with total Medicare billing of $19,952. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Diabetes & Metabolism
- Location Baltimore, MD
- Active Since 05/03/2006
- Last Updated 01/31/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1780642264
Products in Payments
- SYMTUZA (Drug) $16,939
- DELSTRIGO (Drug) $13,900
- EGRIFTA (Drug) $8,619
- DOVATO (Drug) $6,440
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Baltimore
Dr. Shawn Kwatra, M.d, M.D
Internal Medicine — Payments: $978,358
Internal Medicine $978,358
Dr. Aloke Finn, Md, MD
Internal Medicine — Payments: $742,722
Internal Medicine $742,722
David Sidransky, M.d, M.D
Internal Medicine — Payments: $519,965
Internal Medicine $519,965
Dr. Shawn Dhillon, M.d, M.D
Internal Medicine — Payments: $495,197
Internal Medicine $495,197
Mark Levis, M.d, M.D
Internal Medicine — Payments: $450,553
Internal Medicine $450,553
Mark Sulkowski, M.d, M.D
Internal Medicine — Payments: $397,288
Internal Medicine $397,288